INTRODUCTION
Blood stasis patter (BSP) or thrombosis in biomedical terms, which refers to the block in the circulation of blood or meridians, 1 is attributed to a very complicated pathogenesis which mainly involves hemorheology disorder, microcirculatory disturbance, vascular endothelial cell injury and platelet aggregation. Platelet aggregation in blood vessels plays a crucial role in the formation of thrombosis. Inhibiting platelet activation is considered to be an effective way to stop or slow down thrombosis. 5, 6 Therefore, anti-platelet aggregation tests were widely applied to evaluate and investigate cardiovascular disease both in experimental [7] [8] [9] and clinical observations. [10] [11] [12] The adhesiveness and aggregation of platelets will happen due to the impairment of blood vessels or emergency of platelet activation factor, such as adrenaline, adenosine 5-diphosphate (ADP), 5-hydroxytryptamine (5-HT), thromboxane A2 (TXA2) and thrombin (THR) besides collagen. 13 Therefore, there are four main action mechanisms of anti-platelet medicines have been reported such as inhibiting the metabolism of platelet arachidonic acid (AA), increasing the level of platelet cyclic adenosine monophosphate (cAMP), inhibiting the activation of ADP, and blocking the platelet membrane glycoprotein Ⅱb/Ⅲa. 14 Traditional Chinese Medicines (TCM) have a long history. According to records in Huang Di Nei Jing in Chinese), 15 16 in Chinese and Jin Kui Yao Lue 17 in Chinese in the Eastern Han Dynasty, there were several TCMs such as Chuanxiong (Rhizoma Chuanxiong) and Yanhusuo (Rhizoma Corydalis Yanhusuo) had been used for the treatment of BSS. In Tang and Song Dynasty, more TCMs such as Moyao (Myrrha) and Jianghuang (Rhizoma Curcumae Longae) were applied to treat BSS. Actually, in Shen Nong Ben Cao Jing in Chinese, 18 83 of 365 TCMs were recorded with the function of activating blood and resolving stasis. However, to date, the systematic investigation and comparison on the anti-platelet aggregation activities of activating blood and resolving stasis TCMs within one study has not been reported. In the present study, 31 TCMs with the property of activating blood and resolving stasis were selected based on their traditional medical literature. Their extracts were prepared with 90% ethanol (further liquid-liquid extracted by ethyl acetate) and water. The inhibitory effects on rabbit platelet aggregation were induced by AA, ADP and THR of those extracts were investigated.
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MATERIALS AND METHODS
Chemicals and reagents
AA, THR and pentobarbital sodium were obtained from Sigma (St Louis, MO, USA). ADP was the product of Wuhu Huaren Technology Company (Wuhu, Anhui, China). Aspirin and ethanol was purchased from Chengdu Kelong Chemical Reagent Factory (Chengdu, China) and sodium citrate was obtained from Chengdu Aikeda Chemical Reagent Company (Chengdu, China). All other chemicals and reagents were of analytical grade. Thirty-one raw materials of TCMs were obtained from local drugstores (Chongqing Xhoo Medicin Co., Ltd., and Chongqing Hongshengqiao drugstore, Chongqing, China) in Chongqing during autumn of 2012. The voucher specimens of those TCMs were deposited at the School of Chemistry and Chemical Engineering (Chongqing University, Chongqing, China).
Preparation of the extracts
The dried materials of 31 TCMs were ground into fine powder in a pulverizer, respectively. 20 g of the powder was extracted with 60 mL 90% ethanol in an ultrasonic cleanser tank for 20 min, along with reflux extraction for 1 h at 80 ℃, filtered and another fresh 60 mL 90% ethanol was added into the residue, repeated the reflux extraction and filtered. The filtrate was combined and dried at 45 ℃ using a rotary evaporator, and then the residue was re-suspended in 10 mL water and liquid-liquid extraction with 10 mL ethyl acetate for two times. The ethyl acetate extract and the rest solution were separately dried at 45 ℃ using a rotary evaporator and further dried in an oven at 50 ℃. After 90% ethanol extraction, the material residue continued to be reflux extracted by 60 mL × 2 distilled water for twice at 100 ℃, filtered and combined the filtrate. The filtrate solution was evaporated by a rotary evaporator to produce aqueous extract. Finally, the aqueous extract, the rest part after ethyl acetate extraction and ethyl acetate extract of 90% ethanol extract were labeled as A1, A2 and A3, respectively. The extraction yields of each extract for 31 TCMs were between 0.03% to 29.10% . The yields of some extracts such as the A2 and A3 extracts of Xuejie (Sanguis Draconis) were very low, so the anti-platelet aggregation tests for those extracts were done only with one concentration each. A1 extract was dissolved in phosphate buffer saline, A2 in 60% ethanol and A3 in diluted dimethyl sulfoxide (DMSO) before use, respectively.
Preparation of blood plasma sample
Rabbits, males, weighing [(2.2 ± 0.4) kg] were purchased from Animal farm in Chongqing. All experimental procedures were approved by the Institutional Animal Ethical Committee of Chongqing University and were conducted according to the Guide for the Care and Use of Laboratory Animal of the National Institute of Health (Publication No. 80-23, revised 1996) . Rabbit blood samples were collected in 3.8% sodium citrate with the ratio of 9∶1 (blood∶anticoagulant) from carotid artery after anesthetizing by 1% pentobarbital sodium. Platelet-rich plasma (PRP) was obtained by centrifugation at 93 ×g for 15 min at room temperature, and platelet-poor plasma (PPP) was obtained by further centrifugation from the remaining blood at 2325 ×g for 15 min. The concentration of PRP was adjusted to 3 × 10 11 /L by PPP.
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In vitro platelet aggregation assay Platelet aggregation test was performed using the method described in previous report with some modifications. 20 In brief, the level of light transmission was cali-brated as 0% by PPP (300 μL) using SC-2000 platelet aggregometer (Beijing Success Technology Development Co., Ltd., Beijing, China). PRP (300 μL) and different concentrations of extracts (10 μL) were incubated for 3 min at 37 ℃. After incubation, platelet aggregation was induced by adding 10 μL of ADP, THR and AA, respectively, and monitored for 5 min with stirring. DMSO (final concentration: 1.7%), 60% ethanol and PBS were used as blank control for A3, A2 and A1 extracts, respectively. Aspirin was used as the positive control. The percentage of aggregation inhibition is calculated by the following formula:
where I% is the inhibitory percentage, A is maximal aggregation of the blank control test and B is maximal aggregation of drug-treated PRP. Data is expressed as mean ± standard deciation ( x ± s).
RESULTS
Effects of A1 extracts of 31 TCMs on the platelet aggregation
The results (Table 1) indicated that positive drug aspirin showed a strong inhibitory effect on all the platelet aggregation induced by AA, ADP and THR with a concentration-dependent manner. The aqueous extracts (A1) of 31 TCMs exhibited different effects on the platelet aggregation with different inducers (AA, ADP and THR). For ADP as aggregation inducer, Huaihua (Flos Sophorae) had the strongest anti-aggregation effect (even stronger than that of aspirin), while other TCMs with strong anti-aggregation effect (inhibition ratio higher than 40% and with dose-dependent manner) were in the order: 
Effects of A2 extracts of 31 TCMs on platelet aggregation
As shown in Table 2 , the rest part of 90% ethanol extract after liquid-liquid extracting by ethyl acetate (A2) had much weaker anti-aggregation effects. For ADP as aggregation inducer, ten of the tested TCMs had strong inhibitory effect on the aggregation with the order:
For THR as aggregation inducer, seven of the tested TCMs had strong inhibitory effect on the aggregation with the order: Ch- Effects of A3 extracts of 31 TCMs on platelet aggregation As shown in Table 3 , the ethyl acetate extracts from 90% ethanol extracts (A3) had stronger anti-aggregation effects than that of A1 and A2 when using AA as inducer. Fifteen of the tested TCMs had strong inhibitory effect on the aggregation induced by AA with the order:
For ADP as aggregation inducer, fifteen of the tested TCMs had strong inhibitory effect on the aggregation with the order: and Huzhanggen (Radix Polygoni Cuspidati) inhibited platelet aggregation induced by all the three inducers.
DISCUSSION
In this study, we evaluated the anti-platelet aggregation effects of extracts from 31 TCMs with the property of activating blood and resolving stasis in terms of TCM theory.
Our results show that 20 aqueous extracts inhibited platelet aggregation with more than 40% inhibitory ratio induced by THR, which may due to the polypeptides in those aqueous extracts. Furthermore, the metabolic pathway of AA depends on the bioactivity of COX-1 as mentioned above. So it is an effective way to inhibit platelet aggregation by blocking the activity of COX-1. It was reported that natural COX-1 inhibitors usually were flavonoids or polyphenols, pentacyclic triterpenoids, alkaloids, organic acids and so on, 30 which can be extracted by ethyl acetate. Therefore, ethyl acetate extracts (A3) showed higher inhibitory ratio on AA-induced platelet aggregation than A1 and A2 extracts. The results (Table 4) indicate that most of the tested TCMs have anti-platelet aggregation activities, especially for Danshen (Radix Salviae Miltiorrhizae), 31 Danggui (Radix Angelicae Sinensis), 32 Xuanshen (Radix Scrophulariae) 33 and Sanqi (Radix Notoginseng) 34 have strong inhibitory activities on all the aggregation induced by the three inducers (ADP, THR and AA). Therefore, it can be concluded that the anti-platelet aggregation may be one of the most important approaches for the activating blood and resolving stasis activity. Furthermore, the activating blood and resolving stasis TCMs can be classified into four group based on their action mechanisms, 18 and our present results indicated that the anti-platelet aggregation activities of those four groups' TCMs had significant difference Table 3 Inhibition effects on the platelet aggregation of acetate ethyl extracts (A3) of 31 TCMs ( The way for Ligustrazine to inhibit platelet aggregation is to extend platelet aggregation time induced by ADP and liberate the aggregative platelet, while ferulic acid can inhibit platelet release of TXA2 and increase the contents of cAMP. The third group (removing blood stasis and relieving pain) TCMs including Yanhusuo (Rhizoma Corydalis Yanhusuo), Ruxiang (Olibanum), Moyao (Myrrha), Jianghuang (Rhizoma Curcumae Longae), Huzhanggen (Radix Polygoni Cuspidati), Niuxi (Radix Achyranthis Bidentatae), Chuanniuxi (Radix Cyathulae), Chongweizi (Fructus Leonuri Japonici) and Wulingzhi (Faeces Trogopterori) had relative weak inhibitory effect on the platelet aggregation. The last group (breaking and scattering blood thrombosis) TCMs such as Sanleng (Rhizoma Sparganii), Ezhu (Rhizoma Curcumae Phaeocaulis), Taoren (Semen Persicae), Shuizhi (Hirudo), Longxuexie (Sanguis Draconis) and Dahuang (Radix Et Rhizoma Rhei Palmati) also showed relatively weak inhibitory effect on the platelet aggregation. In addition, there are some tested TCMs such as Chuanniuxi (Radix Cyathulae), Niuxi (Radix Achyranthis Bidentatae), Chishao (Radix Paeoniae Rubra), Ruxiang (Olibanum), and Cebaiye (Cacumen Platycladi) didn't show (or with very weak) anti-platelet aggregation activities. As mentioned, the therapeutic mechanisms of activating blood and resolving stasis TCMs on BSP relied on various approaches besides anti-platelet aggregation. For example, Chishao (Radix Paeoniae Rubra) cures BSPmainly through reducing erythrocyte aggregation and blood viscosity, and improving abnormal blood rheology. 37 Furthermore, platelet adherence is one of the major reasons causing BSP and Ruxiang (Olibanum) takes effect on this pathway instead of anti-platelet aggregation. 38 In addition, Chuanniuxi (Radix Cyathulae) and Niuxi (Radix Achyranthis Bidentatae) display curative effects on BSP mainly through improving blood hemorheology. 39 In conclusion, several TCMs such as Chuanxiong (Rhizoma Chuanxiong), Yanhusuo (Rhizoma Corydalis Yanhusuo) and Danshen (Radix Salviae Miltiorrhizae), possess the property of anti-platelet aggregation. a TCMs were listed in alphabetical order; "-": promoting platelet aggregation or with irregular inhibitory effect; "+": the maximum inhibitory rate lower than 40%; "++": the maximum inhibitory rate between 40% and 80%; "+++": the maximum inhibitory rate higher than 80%; TCMs: Traditional Chinese Medicines; ADP: adenosine 5-diphosphate; THR: thrombin; AA: arachidonic acid; A1: aqueous extract; A2: the rest part after ethyl acetate extraction; A3: ethyl acetate extract of 90% ethanol extract.
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